Montag & Caldwell LLC Has $129,302,000 Position in CVS Health Corporation (CVS)
Montag & Caldwell LLC reduced its position in shares of CVS Health Corporation (NYSE:CVS) by 5.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,350,557 shares of the pharmacy operator’s stock after selling 77,129 shares during the period. CVS Health Corporation accounts for approximately 2.6% of Montag & Caldwell LLC’s holdings, making the stock its 14th largest position. Montag & Caldwell LLC owned 0.13% of CVS Health Corporation worth $129,302,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Springbok Capital Management LLC raised its stake in CVS Health Corporation by 190.5% in the first quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator’s stock worth $117,000 after buying an additional 741 shares in the last quarter. MU Investments Co. Ltd. raised its stake in shares of CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock valued at $109,000 after buying an additional 440 shares during the period. Arcadia Investment Management Corp MI raised its stake in shares of CVS Health Corporation by 87.7% in the second quarter. Arcadia Investment Management Corp MI now owns 1,605 shares of the pharmacy operator’s stock valued at $154,000 after buying an additional 750 shares during the period. Physicians Financial Services Inc. raised its stake in shares of CVS Health Corporation by 5.8% in the second quarter. Physicians Financial Services Inc. now owns 1,849 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 101 shares during the period. Finally, Highland Private Wealth Management acquired a new stake in shares of CVS Health Corporation during the first quarter valued at $198,000. 80.89% of the stock is currently owned by institutional investors.
CVS Health Corporation (NYSE:CVS) traded down 2.41% during trading on Monday, hitting $86.66. The stock had a trading volume of 7,381,666 shares. The firm’s 50-day moving average price is $89.92 and its 200-day moving average price is $96.23. The stock has a market cap of $92.40 billion, a PE ratio of 19.94 and a beta of 0.83. CVS Health Corporation has a 1-year low of $85.41 and a 1-year high of $106.67.
CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.30 by $0.02. The business had revenue of $43.70 billion for the quarter, compared to analysts’ expectations of $44.28 billion. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. The business’s quarterly revenue was up 17.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.19 EPS. On average, equities research analysts predict that CVS Health Corporation will post $5.86 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 3rd. Investors of record on Monday, October 24th will be given a $0.425 dividend. This represents a $1.70 annualized dividend and a yield of 1.96%. The ex-dividend date is Thursday, October 20th. CVS Health Corporation’s dividend payout ratio is currently 39.08%.
Several equities research analysts have recently weighed in on the company. Vetr raised CVS Health Corporation from a “hold” rating to a “buy” rating and set a $94.49 target price on the stock in a research report on Monday, October 10th. Credit Suisse Group AG reissued an “outperform” rating and set a $110.00 target price (down previously from $115.00) on shares of CVS Health Corporation in a research report on Tuesday, October 4th. Robert W. Baird cut their target price on CVS Health Corporation from $114.00 to $104.00 and set an “outperform” rating on the stock in a research report on Monday, October 3rd. Leerink Swann reissued an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of CVS Health Corporation in a research report on Sunday, October 2nd. Finally, Mizuho reissued a “buy” rating and set a $111.00 target price on shares of CVS Health Corporation in a research report on Friday, September 30th. Five research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. CVS Health Corporation has an average rating of “Buy” and a consensus target price of $112.40.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.
Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.